Imaging Agents Market
Imaging Agents Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Imaging Agents Market Size and Growth
The Imaging Agents market is experiencing robust growth, driven by advancements in diagnostics and increased prevalence of chronic diseases. The global market size is projected to reach approximately $30 billion by 2026, reflecting a compound annual growth rate (CAGR) of around 7% due to rising demand for innovative imaging technologies and procedures.
Companies Covered
(Covid 19 Impact Covered)
◍ Bayer Healthcare Pharmaceuticals
◍ Bracco Diagnostics
◍ Daiichi Sankyo
◍ Eisai
◍ Eli Lilly and Company
◍ EUSA Pharma
◍ GE Healthcare
◍ Guerbet Group
◍ Lantheus Medical Imaging
◍ Mallinckrodt Pharmaceuticals
◍ Shenzhen Xingjingwei
◍ Beijing Chemical Reagent Research Institute
◍ Lanxing Chemial Materials
◍ Baoding Lucky Chemical
The Imaging Agents Market is competitive, with key players like Bayer, Bracco, and GE Healthcare focusing on innovation and partnerships to enhance diagnostic capabilities. They develop diverse imaging agents, improving patient outcomes and market growth. Sales revenues for select companies include:
- Bayer: $2.5 billion
- GE Healthcare: $19 billion
- Lantheus: $300 million
Request Sample Report
Market Segmentation
By Application
◍ Hospitals & Clinics
◍ Ambulatory Surgical Centers
◍ Diagnostic & imaging centers
Others
By Product
◍ Oncology ◍ Cardiology ◍ Gastrointestinal Disorders
Neurology Disorders
Market Growth
Request Sample Report
$ X Billion USD
